Skip to main content
. 2017 Nov 22;12(11):e0188324. doi: 10.1371/journal.pone.0188324

Fig 2. Immunophenotypic characterization of visASCs cultured for 72 hours under 21% O2(g) or 1% O2(g).

Fig 2

A-B: Percentage of visASCs that expressed CD44, CD140b and CD184 (A) and coexpressed CD140b CD44 or CD140b CD184 (B) according to the metabolic profile of the subjects. C: Correlation of percentage of CD140b+CD44+ and CD140b+CD184+ hypox-visASCs with plasma levels of triglycerides and total cholesterol in the patients. (Nw, n = 3; NonMS, n = 7; MS, n = 7). Significant differences with respect to Nw individuals, Mann-Whitney: * P < 0.05; Significant differences between MS and NonMS patients, Mann-Whitney: † P < 0.05; †† P < 0.01. Nw: normal-weight subjects; NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; Hypox-visASCs: visceral adipose tissue-derived multipotent mesenchymal cells cultured under hypoxic conditions.